| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 03/03/1994 | WO1994004669A1 Mice having cftr defect as model for cystic fibrosis |
| 03/03/1994 | WO1994004552A1 Opioid receptor genes |
| 03/03/1994 | WO1994004196A1 Tumour therapy |
| 03/03/1994 | WO1994004032A1 Composition and method for altering dna sequences by homologous recombination |
| 03/03/1994 | CA2143336A1 Tissue specific transcriptional regulatory element |
| 03/03/1994 | CA2143306A1 Methods and therapeutic compositions for treating cystic fibrosis |
| 03/03/1994 | CA2142305A1 Opioid receptor genes |
| 03/02/1994 | EP0584339A1 Method of delivering therapeutic substances to the brain |
| 03/02/1994 | EP0584287A1 Use of müllerian inhibiting substance for treatment of certain tumors |
| 03/02/1994 | EP0584279A1 Targeted delivery of genes encoding immunogenic proteins |
| 03/02/1994 | EP0584118A1 New conjugates, consisting of a glycoprotein and a nucleic acid-binding substance |
| 02/23/1994 | EP0583917A1 Ampa-binding human GLuR4 receptors |
| 02/22/1994 | CA1327171C Recombinant human cytomegalovirus containing foreign gene and use thereof |
| 02/17/1994 | WO1994003600A1 Morphogenic protein soluble complex and composition thereof |
| 02/17/1994 | WO1994003597A1 Peptides inhibiting ras protein activity, preparation and use thereof |
| 02/17/1994 | WO1994003594A1 Androgen regulation with dna sequences of rat probasin gene |
| 02/17/1994 | WO1994003200A1 Morphogen-induced nerve regeneration and repair |
| 02/17/1994 | WO1994003196A1 New tumor diagnosing or therapeutical probe |
| 02/17/1994 | WO1994003075A2 Morphogen-enriched dietary composition |
| 02/17/1994 | CA2141678A1 New tumor diagnosing or therapeutical probe |
| 02/17/1994 | CA2141556A1 Morphogen-enriched dietary composition |
| 02/17/1994 | CA2141061A1 Peptides inhibiting ras protein activity, preparation and use thereof |
| 02/10/1994 | DE4225569A1 Neue Sonde zur Tumordiagnostik oder Tumortherapie New probe for tumor diagnosis and tumor therapy |
| 02/09/1994 | EP0581848A1 Closed sense and antisense oligonucleotides and uses thereof |
| 02/06/1994 | CA2101586A1 Ampa-binding human glur4 receptors |
| 02/03/1994 | WO1994002637A1 Pseudo-half-knot rna formation by hybridization of antisense oligonucleotides to target rna's secondary structure |
| 02/03/1994 | WO1994002599A1 Advanced glycosylation endproducts to capture transposons modified dna |
| 02/03/1994 | WO1994002501A1 Novel 2'-o-alkyl nucleosides and phosphoramidites processes for the preparation and uses thereof |
| 02/03/1994 | WO1994002499A1 Oligonucleotide alkylphosphonothioates |
| 02/03/1994 | WO1994002498A1 Hybrid oligonucleotide phosphorothioates |
| 02/03/1994 | WO1993021303A3 Enhanced purification and expression of insoluble recombinant proteins |
| 02/03/1994 | CA2490644A1 Hybrid oligonucleotide phosphorothioates |
| 02/03/1994 | CA2140669A1 Pseudo-half-knot rna formation by hybridization of antisense oligonucleotides to target rna's secondary structure |
| 02/03/1994 | CA2140542A1 Oligonucleotide alkylphosphonothioates |
| 02/02/1994 | EP0580795A1 Antisense oligonucleotides to c-kit proto-oncogene and uses thereof |
| 02/01/1994 | US5283185 Mixing aqueous dispersion of cationic lipid and co-lipid with nucleic acids to form complex, incubating cells with complex |
| 02/01/1994 | US5283058 Preventing the cytolysis of lymphocyte by alternating the antigen on donor's cell |
| 01/26/1994 | EP0579791A1 Cellular composition for the treatment of human or animal organisms |
| 01/26/1994 | EP0579771A1 Single-stranded circular oligonucleotides |
| 01/20/1994 | WO1994001558A2 Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor |
| 01/20/1994 | WO1994001552A1 Target antigens of transmission blocking antibodies for malaria parsites |
| 01/20/1994 | WO1994001550A1 Self-stabilized oligonucleotides as therapeutic agents |
| 01/20/1994 | WO1994001545A1 Unstabilising viral quasi-species distributions for avoiding resistance phenomena |
| 01/20/1994 | WO1994001139A1 Targeting somatic gene therapy to joints |
| 01/20/1994 | WO1994001135A1 Method of producing genetically modified astrocytes and uses thereof |
| 01/20/1994 | WO1994001129A1 Use of myoblasts for sustained delivery of gene products |
| 01/20/1994 | WO1994001119A1 INHIBITORS OF PROTEIN TYROSINE-PHOSPHATASE α FOR TREATMENT OF TUMORS |
| 01/20/1994 | CA2139319A1 Self-stabilized oligonucleotides as therapeutic agents |
| 01/20/1994 | CA2138646A1 Target antigens of transmission blocking antibodies for malaria parasites |
| 01/20/1994 | CA2137462A1 Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor |
| 01/20/1994 | CA2137456A1 Use of myoblasts for sustained delivery of gene products |
| 01/19/1994 | EP0578790A1 Synthetic alpha-l-iduronidase and genetic sequences encoding same |
| 01/19/1994 | EP0578776A1 Retrovirus inhibition with antisense nucleic acids complementary to packaging sequences |
| 01/19/1994 | EP0578774A1 Monoclonal antibodies to stem cell factor receptors |
| 01/12/1994 | EP0577648A1 Novel protein polycation conjugates |
| 01/06/1994 | WO1994000573A1 Novel malignant cell type markers of the interior nuclear matrix |
| 01/06/1994 | WO1994000560A1 Matrix for universal donor microvascular endothelial cells |
| 01/06/1994 | WO1994000558A1 DIABETOGENE rad: A TYPE II DIABETES SPECIFIC GENE |
| 01/06/1994 | WO1994000154A1 DNA ENCODING PRECURSOR INTERLEUKIN 1β CONVERTING ENZYME |
| 01/06/1994 | WO1994000133A1 Use of mullerian inhibiting substance for treating tumors and for modulating class 1 major histocompatibility antigen expression |
| 01/06/1994 | WO1994000095A2 Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity |
| 01/06/1994 | WO1993015207A3 Hepatitis therapeutics |
| 01/06/1994 | CA2138807A1 Novel malignant cell type markers of the interior nuclear matrix |
| 01/06/1994 | CA2138124A1 Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity |
| 01/06/1994 | CA2136981A1 Dna encoding precursor interleukin 1.beta. converting enzyme |
| 01/05/1994 | DE4222289C1 Verfahren und Mittel zur Instabilisierung von viralen Quasi-Spezies-Verteilungen unter Vermeidung von Resistenzphänomenen Method and means for instabilization of viral quasi-species distributions while avoiding phenomena of resistance |
| 12/29/1993 | EP0575518A1 Methods and compositions for the selective inhibition of gene expression |
| 12/29/1993 | EP0575350A1 Method for culturing and transforming human stem cell-containing compositions |
| 12/29/1993 | EP0539573A4 Genomic modifications with homologous dna targeting |
| 12/28/1993 | US5273876 Comprising the genomic DNA of Towne strain human CMV, a foreign DNA insert and a promoter sequence |
| 12/23/1993 | WO1993025694A1 Inhibitors of ced-3 and related proteins |
| 12/23/1993 | WO1993025682A2 Chimeric receptor polypeptides, human h13 proteins and uses thereof |
| 12/23/1993 | WO1993025679A1 Novel polypeptides having nmda receptor activity, nucleic acids encoding said polypeptides and applications |
| 12/23/1993 | WO1993025673A1 In vivo gene therapy with intron-free sequence of interest |
| 12/23/1993 | WO1993025660A1 System and method for transplantation of cells |
| 12/23/1993 | WO1993025567A1 Production of recombinant polypeptides by bovine species and transgenic methods |
| 12/23/1993 | WO1993025235A1 Aids therapeutics based on hiv-2 vpx peptides |
| 12/23/1993 | WO1993025234A1 Methods and compositions for targeting specific tissue |
| 12/23/1993 | WO1993022434A3 Targeted cleavage of rna using eukaryotic ribonuclease p and external guide sequence |
| 12/23/1993 | DE4219626A1 Incorporating therapeutic gene via vector into body cells - in=vivo or in vitro, for subsequent expression and secretion of active protein, partic. for treating degenerative diseases of spine and nerves |
| 12/23/1993 | CA2138151A1 New polypeptides with a nmda receptor activity, nucleic acid coding for these polypeptides and their use |
| 12/23/1993 | CA2137914A1 System and method for transplantation of cells |
| 12/23/1993 | CA2137547A1 Chimeric receptor polypeptides, human h13 proteins and uses thereof |
| 12/22/1993 | EP0574579A1 Dna encoding a human 5-ht 1f? receptor and uses thereof |
| 12/22/1993 | EP0574512A1 Redirection of cellular immunity by receptor chimeras |
| 12/21/1993 | US5272263 DNA sequences encoding vascular cell adhesion molecules (VCAMS) |
| 12/21/1993 | US5271941 Antisense oligonucleotides of human regulatory subunit RI.sub.α of cAMP-dependent protein kinases |
| 12/15/1993 | EP0573479A1 Chimeric tar enzyme construction for hiv therapy |
| 12/09/1993 | WO1993024641A2 Adeno-associated virus with inverted terminal repeat sequences as promoter |
| 12/09/1993 | WO1993024640A2 Methods and compositions for in vivo gene therapy |
| 12/09/1993 | WO1993024627A1 Bandage for continuous application of biologicals |
| 12/09/1993 | WO1993024613A1 Improved expression of human multidrug resistance genes and improved selection of cells transduced with such genes |
| 12/09/1993 | WO1993024151A1 Arterial introduction of myoblasts |
| 12/09/1993 | WO1993024134A1 Treatment of cellular hyperproliferation by inhibition of interleukin-1 |
| 12/09/1993 | WO1993024055A1 Method of quantitative determination of bone salt with ct equipment |
| 12/09/1993 | CA2137275A1 Bandage for continuous application of biologicals |
| 12/09/1993 | CA2136349A1 Treatment of cellular hyperproliferation by inhibition of interleukin-1 |
| 12/09/1993 | CA2135645A1 Improved expression of human multidrug resistance genes and improved selection of cells transduced with such genes |
| 12/09/1993 | CA2134773A1 Methods and compositions for in vivo gene therapy |
| 12/08/1993 | EP0572401A1 Viral particles having altered host range |